Trade Filings
Managers Stocks Filings Superinvestors
Signals Institutional Buying Institutional Selling Insider Activity 13D & 13G Watch Sector Rotation
Tools Stock Screener Manager Screener Compare Managers Consensus Baskets All Research Tools Data API
Learn & AI Learn Ask the Data AI Agents
News ★ Saved
About About us Methodology Contact Disclaimer
Reader
DATA PLANS

Historical data downloads — coming with accounts.

API GATEWAY

Free read-only JSON access to the site's cached data.

Dark mode

🧭 Guided View
New to markets — prices, yields, YTD, market cap? We explain every term as you browse, in plain English. Same data, with the help built in.

⚡ Expert View
You already know the market. Just the data — clean, fast and compact, with no extra explanations. This is the default view.

Interface language
Manager record · ✦ curated

Glenview Capital

Larry Robbins (CEO) · New York, NY · CIK 1138995 · EDGAR filings ↗

Healthcare-heavy fundamental manager.

Q2 2026 Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Diff ⇄
$5.49BReported 13F value
45Positions
64.1%Top-10 weight
17.90Effective holdings
12.8%Est. turnover
+12New
−11Exits

Reported 13F portfolio value covers U.S. reportable long positions only — not cash, bonds, shorts or non-U.S. holdings. It is not assets under management.

Reported value by quarter Q2 2024 → Q2 2026
Sector exposure
Healthcare 54.7% (+5.9pp)
Technology 13.8% (-6.9pp)
Financial Services 12.9% (+1.3pp)
Consumer Cyclical 9.9% (-0.7pp)
Communication Services 5.6% (+1.8pp)
Industrials 1.3% (+0.1pp)
Basic Materials 0.9% (-0.6pp)
Energy 0.5% (+0.0pp)
Consumer Defensive 0.2% (-1.0pp)

Share of reported common-equity value; (±pp) vs prior quarter.

The portfolio · Q2 2026
#SecurityWeightValueSharesΔ sharesHeld
1 GPN Global Payments Inc. 12.9% $646.27M 8.91M +40.0% ▲ Add 9+
2 CVS CVS Health Corp. 10.0% $499.13M 4.82M -41.1% ▼ Trim 9+
3 THC Tenet Healthcare Corporation 8.4% $418.25M 2.24M +46.6% ▲ Add 9+
4 TMO Thermo Fisher Scientific… 6.3% $314.47M 627.24K +150.4% ▲ Add 5
5 AMZN Amazon.com, Inc. 6.1% $303.09M 1.27M +20.1% ▲ Add 9+
6 A Agilent Technologies, Inc. 5.2% $261.61M 1.97M New New 1
7 DHR Danaher Corporation 4.4% $218.29M 1.15M +633.3% ▲ Add 5
8 META Meta Platforms, Inc. 4.0% $201.00M 356.84K +190.9% ▲ Add 6
9 AMD Advanced Micro Devices, Inc. 3.5% $173.35M 298.41K -54.1% ▼ Trim 3
10 TEVA Teva Pharmaceutical… 3.4% $172.15M 5.08M -23.7% ▼ Trim 9+
11 VTRS Viatris Inc. 3.1% $156.85M 9.88M +8.7% ▲ Add 9+
12 UBER Uber Technologies, Inc. 2.6% $129.43M 1.79M +23.2% ▲ Add 9+
13 CNC Centene Corp. 2.4% $121.07M 1.89M -41.3% ▼ Trim 4
14 BFLY Butterfly Network, Inc. 2.4% $120.70M 14.34M 0.0% Held 9+
15 CI Cigna Corporation 2.3% $113.64M 412.22K -17.4% ▼ Trim 9+
16 HUM Humana Inc. 2.0% $100.98M 254.22K -24.1% ▼ Trim 2
17 XYZ Block, Inc. 1.8% $90.98M 1.20M -12.3% ▼ Trim 4
18 DKS DICK'S Sporting Goods, Inc. 1.8% $90.97M 401.07K +34.2% ▲ Add 5
19 GENI Genius Sports Limited 1.6% $81.78M 13.50M +57.6% ▲ Add 3
20 ONTO Onto Innovation Inc. 1.6% $77.88M 205.79K -31.3% ▼ Trim 4
21 LLY Eli Lilly and Company 1.4% $69.29M 57.77K New New 1
22 UAL United Airlines Holdings… 1.3% $67.28M 494.74K -0.4% ▼ Trim 6
23 EYE National Vision Holdings… 1.2% $58.95M 3.10M +98.0% ▲ Add 5
24 CSCO Cisco Systems, Inc. 1.0% $48.55M 413.33K +21.6% ▲ Add 2
25 ESI Element Solutions Inc 0.9% $47.49M 994.58K -38.9% ▼ Trim 9+
26 AMAT Applied Materials, Inc. 0.9% $47.14M 65.20K -66.9% ▼ Trim 3
27 MKSI MKS Inc. 0.9% $43.83M 98.53K New New 1
28 FUN Six Flags Entertainment… 0.9% $42.98M 2.02M -9.2% ▼ Trim 3
29 STM STMicroelectronics N.V. 0.8% $41.94M 560.06K New New 1
30 ABBV AbbVie Inc. 0.7% $37.47M 148.91K New New 1
31 AZN AstraZeneca PLC 0.7% $34.94M 184.28K New New 1
32 BLCO Bausch + Lomb Corporation 0.6% $31.76M 1.92M +0.4% ▲ Add 6
33 BKR Baker Hughes Company 0.5% $27.39M 493.52K +62.5% ▲ Add 2
34 ELV Elevance Health Inc. 0.5% $25.76M 66.60K New New 1
35 MCHP Microchip Technology… 0.5% $24.22M 265.58K New New 1
36 BRKR Bruker Corporation 0.3% $15.18M 252.17K New New 1
37 NVS Novartis AG 0.3% $13.62M 86.91K New New 1
38 DOCN DigitalOcean Holdings, Inc. 0.3% $13.32M 84.81K -66.1% ▼ Trim 3
39 PRMB Primo Brands Corporation 0.2% $9.90M 404.97K -23.7% ▼ Trim 2
40 BSX Boston Scientific… 0.1% $4.83M 113.10K New New 1
41 CAH Cardinal Health, Inc. 0.1% $4.28M 18.02K New New 1
42 TECH Bio-Techne Corporation 0.1% $4.12M 58.32K -68.7% ▼ Trim 4

Common-stock (SH) positions only; option lines are in the Options tab and are never netted. ✂ = change computed against split-adjusted prior shares. “Held N+” = held every quarter in our window, possibly longer.

Position age
120–1 quarters
132–4 quarters
75–8 quarters
109+ quarters

Consecutive quarters each current position has been reported, within our data window.

Similar managers
ManagerCommon positionsName overlapWeighted similarity
Holocene Advisors, LP 24 3.0% 0.2532 Compare ⇄
Dodge & Cox 16 6.5% 0.2039 Compare ⇄
Appaloosa 4 6.3% 0.2021 Compare ⇄
Parnassus Investments, Llc 13 7.9% 0.1892 Compare ⇄
Point72 Asset Management 32 1.7% 0.1872 Compare ⇄
Grantham, Mayo, Van Otterloo & Co. LLC 21 3.1% 0.1843 Compare ⇄
Tiger Global Management 7 8.6% 0.1769 Compare ⇄
Boston Partners 26 3.2% 0.1752 Compare ⇄

Similarity of reported longs only — hedges and non-13F assets are invisible. Methodology

Filing record
Aug 14 2026 13F-HR · period Q2 2026

$5.49B · 45 positions · View original SEC filing ↗

May 15 2026 13F-HR · period Q1 2026

$3.98B · 44 positions · View original SEC filing ↗

Feb 17 2026 13F-HR · period Q4 2025

$4.91B · 57 positions · View original SEC filing ↗

Nov 14 2025 13F-HR · period Q3 2025

$4.49B · 54 positions · View original SEC filing ↗

Aug 14 2025 13F-HR · period Q2 2025

$3.57B · 43 positions · View original SEC filing ↗

May 15 2025 13F-HR · period Q1 2025

$4.07B · 45 positions · View original SEC filing ↗

Feb 14 2025 13F-HR · period Q4 2024

$3.96B · 36 positions · View original SEC filing ↗

Nov 14 2024 13F-HR · period Q3 2024

$5.17B · 46 positions · View original SEC filing ↗

Aug 14 2024 13F-HR · period Q2 2024

$5.08B · 48 positions · View original SEC filing ↗

Provenance: All holdings parsed from this manager's 13F information tables on SEC EDGAR; values as reported, whole USD. Changes compare the latest accepted version of each quarter (amendments incorporated) on split-adjusted share counts. Reporting period: Q2 2026 · latest filing Aug 14, 2026 · Change methodology